The DOI matches its Crossref record; 84 of the 90 references it cites were found in a registry or an index; 29 of the 47 sources its claims cite were checked for support.
SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma
Open accessAbstract
The Sonic Hedgehog (SHH) pathway is crucial regulator of embryonic development and stemness. Its alteration leads to medulloblastoma (MB), the most common malignant pediatric brain tumor. The SHH-MB subgroup is the best genetically characterized, however the molecular mechanisms responsible for its pathogenesis are not fully understood and therapeutic benefits are still limited. Here, we show that the pro-oncogenic stemness regulator Spalt-like transcriptional factor 4 (SALL4) is re-expressed in mouse SHH-MB models, and its high levels correlate with worse overall survival in SHH-MB patients. Proteomic analysis revealed that SALL4 interacts with REN/KCTD11 (here REN), a substrate receptor subunit of the Cullin3-RING ubiquitin ligase complex (CRL3 REN ) and a tumor suppressor lost in ~30% of human SHH-MBs. We demonstrate that CRL3 REN induces polyubiquitylation and degradation of wild type SALL4, but not of a SALL4 mutant lacking zinc finger cluster 1 domain (ΔZFC1). Interestingly, SALL4 binds GLI1 and cooperates with HDAC1 to potentiate GLI1 deacetylation and transcriptional activity. Notably, inhibition of SALL4 suppresses SHH-MB growth both in murine and patient-derived xenograft models. Our findings identify SALL4 as a CRL3 REN substrate and a promising therapeutic target in SHH-dependent cancers.
Overview
CoChat Summary
TL;DR
This study identifies SALL4 as a CRL3REN/KCTD11 substrate in Sonic Hedgehog (SHH)-dependent medulloblastoma and shows that SALL4 promotes tumor growth by cooperating with HDAC1 and GLI1 to enhance SHH signaling. The authors report that SALL4 inhibition suppresses SHH-MB growth in cell culture, mouse models, and patient-derived xenografts.
Key findings
- Proteomic screening of REN/KCTD11 interactors recovered SALL4, and co-immunoprecipitation confirmed REN binds SALL4; CRL3REN promoted SALL4 polyubiquitylation and proteasomal degradation, while the SALL4 ΔZFC1 mutant was resistant to this regulation.
- In Cavalli SHH-MB patient data (GSE85217), high SALL4 expression was associated with worse prognosis in SHH-MB patients; subtype analysis showed lower SALL4 in gamma than in alpha, beta, and delta subtypes.
- SALL4 increased GLI1-responsive transcription in a dose-dependent manner, decreased AcGLI1 (acetyl-K518-GLI1), and formed a trimeric complex with GLI1 and HDAC1 to enhance SHH signaling.
- SALL4 depletion reduced proliferation and SHH transcriptional output in Med1-MB cells and primary SHH-MB cells; in PDX cells, SALL4 depletion lowered the S phase from 12.75% to 4.03% and increased G2 from 6.185% to 13.75%.
Methods
- The study combined immunoaffinity purification/mass spectrometry, co-immunoprecipitation, ubiquitination assays, luciferase reporter assays, qRT-PCR, immunoblotting, and cell proliferation/cell cycle analyses.
- Models included HEK293T cells, Med1-MB cells, primary murine SHH-MB cells from Math1-cre/Ptcfl/fl mice, GNP cultures, and two human SHH-MB PDX models (ICN-MB-PDX12 and Med-1712FH).
- In vivo work used heterotopic subcutaneous allografts in nu/nu mice (n = 4) and orthotopic cerebellar allografts in nu/nu mice (n = 6 per group), with tumor growth measured after SALL4 knockdown.
Limitations
- The paper does not report detailed quantitative results for several in vivo experiments in the text provided; some outcomes are described qualitatively or refer to figures.
- The study focuses on preclinical models and dataset analysis; no clinical intervention or prospective patient cohort is reported (stated by the text).
- The text does not provide a full breakdown of sample sizes for all assays and datasets used, beyond the explicitly stated animal-group sizes and the two PDX models (evident from the text).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4 SALL4 cooperates with HDAC1 in reducing GLI1 acetylation levels. A GLI1-induced transcription has been assessed in HEK293Ts transiently transfected with 12 × GLI1-BS Firefly luciferase, pRL-TK Renilla as normalization control, and the indicated plasmids; data are expressed as FC versus empty vector. Co-IPs of SALL4 and ectopic or endogenous HDAC1 (B, C, respectively), or ectopic or endogenous GLI1 (D, E, respectively) in HEK293Ts transiently transfected as indicated. F Co-IPs of GLI1, SALL4, and HDAC1 in HEK293Ts transiently transfected with vectors expressing the indicated plasmids. G Densitometric analysis of relative GLI1/SALL4 and GLI1/HDAC1 binding affinities, expressed as FC versus relative controls, are normalized to immunoprecipitated Flag-GLI1. H HEK293Ts were transfected with different combinations of indicated plasmids. Protein lysates were immunoprecipitated with anti-Flag agarose beads. One-third of immunocomplexes was probed with antibodies to the indicated proteins (1st IP), whereas two-thirds were subjected to two elutions with Flag-peptide and re-immunoprecipitated with HA-agarose beads followed by immunoblotting as indicated (2nd IP). I Co-IP of Flag-GLI1 in HEK293Ts transiently transfected with indicated plasmids. The acetylation levels of GLI1 protein at K518 residue have been assessed by using an in-house generated antibody [39]. Total protein lysates are shown in the Input. J Densitometric analysis of relative AcGLI1 levels, normalized to immunoprecipitated Flag-GLI1. K GLI1-dependent transcription has been assessed in HEK293Ts transiently transfected with 12 × GLI1-BS Firefly luciferase, pRL-TK Renilla as normalization control, and indicated plasmids. Data are expressed as FC versus empty vector. Representative immunoblotting of n = 3 biological replicas with similar results are shown in B–F, H, and I. Densitometric analysis in G and J represent the mean of n = 3 independent experiments ± SD; *p < 0.05 *p < 0.05; **p < 0.01; ***p < 0.001 calculated with two-sided Student’s t-test.](https://figures.cochat.ai/paper-figures/80df164e55f040838269b5585fb74f7d/sall4-is-a-crl3ren-kctd11-substrate-that-drives-sonic-hedgehog-dependent-figure-4.jpg)




Verification
Claims the paper makes
19 Valid · 1 Not valid · 10 Not checked · 70 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“while SALL4 genetic depletion or MGCD0103 treatment alone restrains tumor cell proliferation, their combination does not further induce the inhibition of SHH-MB cells proliferative capability”
§ SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma > Results > SALL4 genetic depletion inhibits SHH-MB cells growth in vitro
What the sources say
- Partly supportedcites [45] Coni S, Mancuso AB, Di Magno L, Sdruscia G, Manni S, Serrao SM, et al. Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma. Sci Rep. 2017;7:44079. sourceExperimental — accuracy not yet measured
The Results section on pharmacological blockade of HDAC1/2 reports that MGCD0103 alone significantly reduced proliferation in Med1-MB cells (page unavailable). Our copy does not report SALL4 depletion or compare its combination with MGCD0103 against either treatment alone; searches for SALL4 and combined knockdown did not establish that part of the claim. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Thal efficiently directs SALL4 to Cullin4/Cereblon (CRL4CRBN)-mediated degradation [49, 50] exclusively in humans, primates, and rabbits [48].”
§ SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma > Results > SALL4 depletion represses human SHH-MB growth
What the sources say
- Partly supportedcites [48] Donovan KA, An J, Nowak RP, Yuan JC, Fink EC, Berry BC, et al. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome. Elife. 2018;7:e38430. sourceExperimental — accuracy not yet measured
The Results section on species-specific teratogenicity links sensitivity to CRBN and SALL4 sequence and says some non-human primates and rabbits resemble the human phenotype. It does not establish that SALL4 degradation occurs exclusively in the listed species; it also identifies the greater bush baby as an insensitive non-human primate. The citation to this paper is attached to the exclusivity clause, rather than the preceding degradation-mechanism clause. No page number is provided in our copy. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [49] Matyskiela ME, Clayton T, Zheng X, Mayne C, Tran E, Carpenter A, et al. Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex. Nat Struct Mol Biol. 2020;27:319–22. source
- Could not verifycites [50] Sievers QL, Petzold G, Bunker RD, Renneville A, Słabicki M, Liddicoat BJ, et al. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science 2018;362:eaat0572. sourceExperimental — accuracy not yet measured
Citation [48] is attached to the claim that SALL4 degradation occurs exclusively in humans, primates, and rabbits. The section “Different thalidomide analogs target distinct sets of ZFs for degradation” reports mild degradation of SALL4 ZF2 by CC-885, but our copy provides no comparison across those species or evidence for exclusivity (searched: rabbits, primates, SALL4 thalidomide degradation). (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Interestingly mocetinostat, a selective inhibitor of HDAC1 and HDAC2, drastically reduces SHH-MB growth in mouse models, an effect linked to GLI1 acetylation [45], thereby suggesting the potential of mocetinostat to counteract, at the same time, SALL4 activity.”
§ SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma > Discussion
What the sources say
- Supportedcites [45] Coni S, Mancuso AB, Di Magno L, Sdruscia G, Manni S, Serrao SM, et al. Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma. Sci Rep. 2017;7:44079. source
The Abstract identifies mocetinostat as a selective HDAC1/HDAC2 inhibitor and reports that administering it to mouse models of SHH-MB drastically reduces tumor growth. It also links the drug’s effect to Gli1 acetylation. The sentence’s suggestion about SALL4 is the citing authors’ inference, not a finding attributed to this source. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The recent discovery that the small immunomodulatory drug thalidomide induces ubiquitylation and degradation of SALL4 by the CRL4CRBN E3 ubiquitin ligase [50] has demonstrated that this transcription factor can be targeted for cancer therapy [48, 50].”
§ SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma > Discussion
What the sources say
- Partly supportedcites [48] Donovan KA, An J, Nowak RP, Yuan JC, Fink EC, Berry BC, et al. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome. Elife. 2018;7:e38430. sourceExperimental — accuracy not yet measured
The Results section (page not provided) establishes that thalidomide induces CRL4CRBN-dependent ubiquitylation and degradation of SALL4, including in cultured cells. This demonstrates that SALL4 can be pharmacologically targeted, but the cited paper does not demonstrate that targeting it is effective as cancer therapy. (LLM, conf=0.84)
- Partly supportedcites [50] Sievers QL, Petzold G, Bunker RD, Renneville A, Słabicki M, Liddicoat BJ, et al. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science 2018;362:eaat0572. sourceExperimental — accuracy not yet measured
The section on different thalidomide analogs reports mild but significant degradation of a SALL4 zinc-finger reporter by CC-885 and describes such targets as candidates for drug development. The Discussion proposes therapeutic targeting of zinc-finger transcription factors generally, but links SALL4 specifically to development and possible thalidomide-related fetal abnormalities, not to demonstrated cancer therapy. (LLM, conf=0.87)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Interestingly mocetinostat, a selective inhibitor of HDAC1 and HDAC2, drastically reduces SHH-MB growth in mouse models, an effect linked to GLI1 acetylation [45], thereby suggesting the potential of mocetinostat to counteract, at the same time, SALL4 activity.”
§ SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma > Discussion
What the sources say
- Supportedcites [45] Coni S, Mancuso AB, Di Magno L, Sdruscia G, Manni S, Serrao SM, et al. Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma. Sci Rep. 2017;7:44079. source
The Results section reports that mocetinostat inhibited proliferation in medulloblastoma cells expressing wild-type Gli1, but not cells expressing a non-acetylatable Gli1 mutant. The Discussion explicitly links its antitumor effect to Gli acetylation. Page numbers were not supplied. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
65 more claims · 2 with their cited sources checked
Create a free account to see all 100 claims and every source verdict.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 16
- The quote only partly states this claim. 1
Citations
Cites
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Altered Neural Cell Fates and Medulloblastoma in Mouse patched Mutants
Goodrich, L. V., Milenković, L., Higgins, K. M., & Scott, M. P. (1997) · Science · doi:10.1126/science.277.5329.1109 · Cited by 1,696
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Cavalli, F. M. G., Remke, M., Rampasek, L., Peacock, J., Shih, D. J. H., Luu, B., Garzia, L., Torchia, J., Nor, C., Morrissy, A. S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.005 · Cited by 1,219
Hedgehog Signaling in Development and Cancer
Jiang, J., & Hui, C.-C. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.11.010 · Cited by 1,063 · cited 1×
“GLI1 is the main downstream effector of the pathway that, by driving its own expression, provides a positive feedback loop and reinforces the signaling strength [5].”
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Kool, M., Jones, D. T. W., Jäger, N., Northcott, P. A., Pugh, T. J., Hovestadt, V., Piro, R. M., Esparza, L. A., Markant, S. L., Remke, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.004 · Cited by 762
Sasaki, H., Nishizaki, Y., Hui, C.-C., Nakafuku, M., & Kondoh, H. (1999) · Development · doi:10.1242/dev.126.17.3915 · Cited by 715
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Khan, N., Jeffers, M., Kumar, S., Hackett, C., Boldog, F., Khramtsov, N., Qian, X., Mills, E., Berghs, S. C., Carey, N., et al. (2008) · Biochemical Journal · doi:10.1042/bj20070779 · Cited by 713 · cited 1×
“…100 μ g/ml up to 8 h; Sigma-Aldrich), mocetinostat (MGCD0103, 0.5 μ M up to 72 h; synthetized in house as a dihydrobromide salt as described in [80]), thalidomide (Thal, 10 – 20 μ M up to 72 h; Tocris Bioscience, Bristol, UK), and Smoothened Agonist (SAG, 200 nM, Alexis Biochemicals,…”
InfluentialYang, Z.-J., Ellis, T., Markant, S. L., Read, T.-A., Kessler, J. D., Bourboulas, M., Schüller, U., Machold, R., Fishell, G., Rowitch, D. H., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.003 · Cited by 698
Zhang, J., Tam, W.-L., Tong, G. Q., Wu, Q., Chan, H.-Y., Soh, B.-S., Lou, Y., Yang, J., Ma, Y., Chai, L., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1481 · Cited by 568 · cited 1×
“SALL4 is a zinc fi nger transcription factor mainly expressed in embryonic stem cells and implicated in the maintenance of pluripotency by its interaction with NANOG and OCT4, two of the main embryonic stemness markers [13, 14].”
Cited by
A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3
Balasco, N., Esposito, L., Smaldone, G., Salvatore, M., & Vitagliano, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031881 · Cited by 15
SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms
Wang, T., Jin, Y., Wang, M., Chen, B., Sun, J., Zhang, J., Yang, H., Deng, X., Cao, X., Wang, L., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00812-z · Cited by 9
Mohammed, H. S., Hosny, E. N., Sawie, H. G., & Khadrawy, Y. A. (2023) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-023-00497-z · Cited by 11
Wang, B., Xu, T., Qiu, C., Yu, L., Xu, S., Zhao, X., Xu, C., Tan, F., Sheng, H., & Zhang, N. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113075 · Cited by 3
SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation
Bordin, F., Terriaca, G., Apostolico, A., Fiore, A. D., Mir, F. T., Bellardinelli, S., Bufalieri, F., Bordone, R., Belardinilli, F., Giannini, G., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02260-4 · Cited by 9
“Dimethyl sulfoxide (DMSO) (Sigma) was added in equivalent amounts as a control.”
Self-citation
Metadata
- Authors
- Lospinoso Severini, L., Loricchio, E., Navacci, S., Basili, I., Alfonsi, R., Bernardi, F., Moretti, M., Conenna, M., Cucinotta, A., Coni, S., Petroni, M., De Smaele, E., Giannini, G., Maroder, M., Canettieri, G., Mastronuzzi, A., Guardavaccaro, D., Ayrault, O., Infante, P., Bufalieri, F., & Di Marcotullio, L.
- Affiliations
- Sapienza University of Rome (IT)
- Centre National de la Recherche Scientifique (FR)
- Istituto Superiore di Sanità (IT)
- Université Paris-Sud (FR)
- Istituto Pasteur (IT)
- Bambino Gesù Children's Hospital (IT)
- University of Verona (IT)
- Corresponding author
- Bufalieri, Francesca
- ORCID
- Loricchio, Elena
- Basili, Irene
- Alfonsi, Romina
- Bernardi, Flavia
- Moretti, Marta
- Cucinotta, Antonino
- Coni, Sonia
- Petroni, Marialaura
- De Smaele, Enrico
- Giannini, Giuseppe
- Maroder, Marella
- Canettieri, Gianluca
- Mastronuzzi, Angela
- Guardavaccaro, Daniele
- Ayrault, Olivier
- Infante, Paola
- Bufalieri, Francesca
- Di Marcotullio, Lucia
- Venue
- Cell Death & Differentiation
- Published
- 2023-12-07
- Volume
- 31
- Issue
- 2
- Pages
- 170-187
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- PMC
- PMC10850099
- OpenAlex
- W4389455285
- Semantic Scholar
- 139a9e91813de5660b541879c762000f163f4cd7
- Cited by
- 13
- References
- 90
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 1
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death and Differentiation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, other-oa)
- Funders
- Dipartimenti di Eccellenza (L.232/2016, 232/2016)
- Ministero della Salute (PRIN2017BF3PXZ)
- Istituto Pasteur-Fondazione Cenci Bolognetti
- Associazione Italiana per la Ricerca sul Cancro (MFAG 2021-ID. 26536, 2017BF3PXZ, IG 20801, MFAG 2021, IG 25833, IG-24329)
- NextGenerationEU
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- SALL4, medulloblastoma, sonic hedgehog pathway, ubiquitination, protein degradation, Gli1, HDAC1, transcriptional regulation, cancer stemness, therapeutic target, pediatric brain tumors
- MeSH terms
- Zinc Finger Protein GLI1, Animals, Brain Neoplasms, Cerebellar Neoplasms, DNA-Binding Proteins, Humans, Medulloblastoma, Transcription Factors, Transferases, Cell Cycle Proteins, Proteomics, Mice, Hedgehog Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma. https://app.cochat.ai/papers/10.1038/s41418-023-01246-6
- The paper
- Lospinoso Severini, L., Loricchio, E., Navacci, S., Basili, I., Alfonsi, R., Bernardi, F., Moretti, M., Conenna, M., Cucinotta, A., Coni, S., Petroni, M., De Smaele, E., Giannini, G., Maroder, M., Canettieri, G., Mastronuzzi, A., Guardavaccaro, D., Ayrault, O., Infante, P., . . . Di Marcotullio, L. (2024). SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma. Cell Death & Differentiation. https://doi.org/10.1038/s41418-023-01246-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.